Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT02525198Not ApplicableCompleted

The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial

NCT04347421Not ApplicableCompletedPrimary

Effect of Krill Oil on Cognitive Function in Adults

NCT03849391Not ApplicableCompletedPrimary

Effect of Skate Skin Extract on Cognitive Function in Adults

Showing all 3 trials

Research Network

Activity Timeline